Sagimet Biosciences Inc

SGMTNASDAQ · USD
10.42USD0.00 (-6.05%)
2310

Sagimet Biosciences Inc (SGMT) Option Chain

As of September 23, 2026, Sagimet Biosciences Inc is trading at $10.42, a -6.05% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 76.6%. IV Rank is 8%.

Read more

Tracking the SGMT option chain helps you see every strike and expiry on Sagimet Biosciences Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Sagimet Biosciences Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of SGMT options activity at a glance. Use our scanner to monitor the SGMT option chain in real time and filter for the SGMT options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For SGMT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the SGMT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where SGMT stock options are being actively traded and where they are not.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Sagimet Biosciences Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen SGMT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of SGMT stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile42.46% Neutral
  • Market cap (M$)642
  • 52 weeks high-9.00%
  • 52 weeks low131.56%
  • Analyst recommendationStrong Buy
    1.08
  • Target price$29.33
    181.48% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-12
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.28
  • EPS growth next 5 years-1.51%

As of September 23, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.0034400.635.423.708.405.00-54.91—0.050.000.0501,941100.00
2.2424100.132.921.504.607.50-32.37—0.100.000.10033397.76
31.862,776121.080.421.451.5510.00-9.830.350.500.000.43312,24268.14
76.3779790.330.000.250.4012.50+12.711.651.802.08-0.3601023.63
95.451,1822950.150.00—0.1515.00+35.261.606.204.58-0.68014.55

As of September 23, 2026

Scan the full option chain in one place

Browse the full SGMT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial